Meng Shen

2.2k total citations
62 papers, 1.5k citations indexed

About

Meng Shen is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Meng Shen has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 21 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Meng Shen's work include Cancer Immunotherapy and Biomarkers (10 papers), Immune cells in cancer (6 papers) and MicroRNA in disease regulation (5 papers). Meng Shen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immune cells in cancer (6 papers) and MicroRNA in disease regulation (5 papers). Meng Shen collaborates with scholars based in China, Taiwan and United States. Meng Shen's co-authors include Xiubao Ren, Fei‐Ran Gong, Qiaoming Zhi, Mengyao Wu, Min Tao, Shizhen Emily Wang, Jian Wang, Qian Sun, Mengdan Xu and Wei Yan and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Meng Shen

59 papers receiving 1.5k citations

Peers

Meng Shen
Mengyu Feng China
Serge Haan Luxembourg
Yong Qin China
Long Yuan China
Jing Du China
Hongling Peng China
Wenzhi Shen China
Xiaonan Hou United States
Linyong Du China
Mengyu Feng China
Meng Shen
Citations per year, relative to Meng Shen Meng Shen (= 1×) peers Mengyu Feng

Countries citing papers authored by Meng Shen

Since Specialization
Citations

This map shows the geographic impact of Meng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Shen more than expected).

Fields of papers citing papers by Meng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Shen. The network helps show where Meng Shen may publish in the future.

Co-authorship network of co-authors of Meng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Shen. A scholar is included among the top collaborators of Meng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Shen. Meng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Y., Meng Shen, Jie Jin, et al.. (2025). Shen-Bai-Jie-Du decoction inhibits colorectal tumorigenesis by attenuating the malignancy of cancer stem cells via the gut microbiota-bile acid-FXR axis. Phytomedicine. 148. 157366–157366. 1 indexed citations
3.
Dong, Hua, Xiexing Wu, Jiale Wang, et al.. (2025). Nanoparticles, a promising treatment for gastric cancer. SHILAP Revista de lepidopterología. 6(1). 23–55. 1 indexed citations
4.
Zhao, Hua, Shaochuan Liu, Wenwen Yu, et al.. (2024). Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for lung adenocarcinoma in preclinical trials. Journal of Leukocyte Biology. 116(3). 544–554. 3 indexed citations
5.
Shen, Meng, et al.. (2024). Intermediate service input distortions and total factor productivity: Evidence from China. PLoS ONE. 19(1). e0296429–e0296429. 1 indexed citations
6.
Huang, Min, Y. Zhang, Meng Shen, et al.. (2024). Shen-Bai-Jie-Du decoction suppresses the progression of colorectal adenoma to carcinoma through regulating gut microbiota and short-chain fatty acids. Chinese Medicine. 19(1). 149–149. 4 indexed citations
7.
8.
Meng, Yuan, Lin Yang, Meng Shen, et al.. (2021). Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events. Cancer Biology and Medicine. 18(-). 0–0. 6 indexed citations
9.
Shen, Meng, Mengyao Wu, Qiaoming Zhi, et al.. (2021). Author Correction: Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA. Scientific Reports. 11(1). 5063–5063. 1 indexed citations
10.
Guo, Li, Guangyan Wang, Shan Cui, et al.. (2020). microRNA-15b contributes to depression-like behavior in mice by affecting synaptic protein levels and function in the nucleus accumbens. Journal of Biological Chemistry. 295(20). 6831–6848. 23 indexed citations
11.
Shen, Meng, Chuan Dong, Xianhui Ruan, et al.. (2019). Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting ONECUT2. Cancer Research. 79(14). 3608–3621. 153 indexed citations
12.
Lu, Yujie, Wen‐Jie Wang, Min Jiang, et al.. (2019). Prognostic values of platelet-associated indicators in advanced breast cancer. Translational Cancer Research. 8(4). 1326–1335. 1 indexed citations
13.
Liu, Liang, Lin Yang, Wei Yan, et al.. (2018). Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis. Clinical Cancer Research. 24(10). 2370–2382. 44 indexed citations
14.
Shen, Meng & Xiubao Ren. (2018). New insights into the biological impacts of immune cell-derived exosomes within the tumor environment. Cancer Letters. 431. 115–122. 62 indexed citations
15.
Wu, Xiao Yu, Mengyao Wu, Min Jiang, et al.. (2017). TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells. Cancer Cell International. 17(1). 13–13. 61 indexed citations
16.
Zhao, Qian, Wei Xiao, Yan Chen, et al.. (2017). Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma. Medicine. 96(35). e7920–e7920. 17 indexed citations
17.
Wang, Wenjie, Mengyao Wu, Meng Shen, et al.. (2015). Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib. International Journal of Oncology. 47(5). 1912–1922. 35 indexed citations
18.
Li, Wei, Mengyao Wu, Rongrui Liang, et al.. (2015). FH535 inhibited metastasis and growth of pancreatic cancer cells. OncoTargets and Therapy. 8. 1651–1651. 14 indexed citations
19.
20.
Shen, Meng, et al.. (2002). Osmotic Shrinkage of Human Cervical Cancer Cells Induces an Extracellular Cl−-dependent Nonselective Cation Channel, Which Requires p38 MAPK. Journal of Biological Chemistry. 277(48). 45776–45784. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengyu Feng Breakdown of academic impact, for papers by Serge Haan Breakdown of academic impact, for papers by Yong Qin Breakdown of academic impact, for papers by Long Yuan Breakdown of academic impact, for papers by Jing Du Breakdown of academic impact, for papers by Hongling Peng Breakdown of academic impact, for papers by Wenzhi Shen Breakdown of academic impact, for papers by Xiaonan Hou Breakdown of academic impact, for papers by Linyong Du
Rankless by CCL
2026